![David Sherman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de David Sherman
Anciens postes connus de David Sherman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Lifesci Advisors LLC (Research) | Analyst-Equity | - | 01/09/2021 |
LifeSci Capital LLC
![]() LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank based in New York, NY. LifeSci Capital LLC provides financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. The company also has a highly regarded team of analysts who generate differentiated, proprietary research and cover companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Dan Alan Wychulis has been the CEO of the company since 2024. | Analyst-Equity | 01/04/2014 | 01/09/2021 |
Directeur de la Recherche - Actions | 01/04/2014 | 01/09/2021 |
Formation de David Sherman
David Geffen School of Medicine | Doctorate Degree |
Harvard College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Analyst-Equity | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Lifesci Advisors LLC (Research) | Finance |
LifeSci Capital LLC
![]() LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank based in New York, NY. LifeSci Capital LLC provides financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. The company also has a highly regarded team of analysts who generate differentiated, proprietary research and cover companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Dan Alan Wychulis has been the CEO of the company since 2024. | Finance |
- Bourse
- Insiders
- David Sherman
- Expérience